These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 25774838)
1. Effect of Feedback Signal on Blood Pressure Self-regulation Capability in Individuals With Prehypertension or Stage I Hypertension: A Randomized Controlled Study. Wang MY; Chang NC; Hsieh MH; Su CT; Liu JC; Shyu YK; Tsai PS J Cardiovasc Nurs; 2016; 31(2):166-72. PubMed ID: 25774838 [TBL] [Abstract][Full Text] [Related]
2. Blood pressure biofeedback exerts intermediate-term effects on blood pressure and pressure reactivity in individuals with mild hypertension: a randomized controlled study. Tsai PS; Chang NC; Chang WY; Lee PH; Wang MY J Altern Complement Med; 2007 Jun; 13(5):547-54. PubMed ID: 17604559 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension. Germino FW Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484 [TBL] [Abstract][Full Text] [Related]
4. Effect of slow abdominal breathing combined with biofeedback on blood pressure and heart rate variability in prehypertension. Wang SZ; Li S; Xu XY; Lin GP; Shao L; Zhao Y; Wang TH J Altern Complement Med; 2010 Oct; 16(10):1039-45. PubMed ID: 20954960 [TBL] [Abstract][Full Text] [Related]
5. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH). Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD; Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460 [TBL] [Abstract][Full Text] [Related]
6. Nebivolol monotherapy for patients with systolic stage II hypertension: results of a randomized, placebo-controlled trial. Lewin A; Punzi H; Luo X; Stapff M Clin Ther; 2013 Feb; 35(2):142-52. PubMed ID: 23332366 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM. Oigman W; Gomes MA; Pereira-Barretto AC; Póvoa R; Kohlmann O; Rocha JC; Nobre F Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755 [TBL] [Abstract][Full Text] [Related]
8. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial. Weiss RJ; Stapff M; Lin Y Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial. Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480 [TBL] [Abstract][Full Text] [Related]
11. Biofeedback-assisted cardiovascular control in hypertensives exposed to emotional stress: a pilot study. Palomba D; Ghisi M; Scozzari S; Sarlo M; Bonso E; Dorigatti F; Palatini P Appl Psychophysiol Biofeedback; 2011 Sep; 36(3):185-92. PubMed ID: 21656149 [TBL] [Abstract][Full Text] [Related]
12. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study. Shimada K; Ogihara T; Saruta T; Kuramoto K; Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495 [TBL] [Abstract][Full Text] [Related]
13. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006 [TBL] [Abstract][Full Text] [Related]
14. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring. Lacourcière Y; Neutel JM; Davidai G; Koval S Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201 [TBL] [Abstract][Full Text] [Related]
15. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials. Lacourcière Y; Neutel JM; Schumacher H Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450 [TBL] [Abstract][Full Text] [Related]
16. Randomized, controlled trial of qigong for treatment of prehypertension and mild essential hypertension. Park JE; Hong S; Lee M; Park T; Kang K; Jung H; Shin KM; Liu Y; Shin M; Choi SM Altern Ther Health Med; 2014; 20(4):21-30. PubMed ID: 25141360 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of initial therapy with single-pill combination telmisartan/hydrochlorothiazide 80/25 mg in patients with grade 2 or 3 hypertension: a multinational, randomized, double-blind, active-controlled trial. Zhu DL; Bays H; Gao P; Mattheus M; Voelker B; Ruilope LM Clin Ther; 2012 Jul; 34(7):1613-24. PubMed ID: 22717420 [TBL] [Abstract][Full Text] [Related]
18. Relaxation training for essential hypertension at the worksite: I. The untreated mild hypertensive. Chesney MA; Black GW; Swan GE; Ward MM Psychosom Med; 1987; 49(3):250-63. PubMed ID: 3299442 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of once-daily oral fimasartan 20 to 240 mg/d in Korean Patients with hypertension: findings from Two Phase II, randomized, double-blind, placebo-controlled studies. Lee H; Yang HM; Lee HY; Kim JJ; Choi DJ; Seung KB; Jeon ES; Ha JW; Rim SJ; Park JB; Shin JH; Oh BH Clin Ther; 2012 Jun; 34(6):1273-89. PubMed ID: 22608107 [TBL] [Abstract][Full Text] [Related]
20. Acupuncture lowers blood pressure in mild hypertension patients: a randomized, controlled, assessor-blinded pilot trial. Liu Y; Park JE; Shin KM; Lee M; Jung HJ; Kim AR; Jung SY; Yoo HR; Sang KO; Choi SM Complement Ther Med; 2015 Oct; 23(5):658-65. PubMed ID: 26365445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]